Impact of STARTRK-2 on Clinical Practice - 102164

Spotlight
Video

Impact of STARTRK-2 on Clinical Practice

Loading........
Description: Jonathan Lim, MD, Chairman and CEO of Ignyta, Inc. explains the impact of Entrectinib and the STARTRK-2 trial on clinical practice and future clinical trials. This was recorded at the 2017 ASCO Annual Meeting in Chicago, IL.
Shared By : AnnualMeeting2017
Posted on : 06/06/17
Added : 9 months ago
Category : Other



Recommended

Nothing found.

More From AnnualMeeting2017

Nothing found.